Equity · Healthcare

ESPR

Esperion Therapeutics, Inc. · NasdaqGM

$3.19 +0.16% 1D Finazon · prior-day close · Jul 10, 2026

Price · Chart

Our own end-of-day closes 20 sessions

$3.20 $3.14 11 Jun 10 Jul

The line runs $3.15 on 11 June through $3.19 on 10 July, on a scale from $3.14 to $3.20. Days the market did not trade hold the previous close, flat.

The chart above plots the price of ESPR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 20 sessions over that window: $3.15 on 11 June 2026 through $3.19 on 10 July 2026.

Market cap $821.2M

52-week range $1.11 – $4.08

Avg volume 2.0M

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 8, 2026

ESPR insider trades

SEC Form 4 · last 90 days · newest reported trade 17 Jun 2026

Open-market buys 0

Open-market sells 3

Net sold $240K

Non-trade filings 9

Date Insider Type Shares Value

17 Jun 2026 Halladay Benjamin Chief Financial Officer Sell 10,773 $34K

17 Jun 2026 Koenig Sheldon L. President and CEO Sell 53,588 $169K

17 Jun 2026 Looker Benjamin Chief Legal Officer Sell 11,824 $37K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value

13 Jul 2026 CARROLL J MARTIN Director Other 177,523

13 Jul 2026 Koenig Sheldon L. President and CEO Other 2,121,094

13 Jul 2026 Halladay Benjamin Chief Financial Officer Other 705,410

13 Jul 2026 Looker Benjamin Chief Legal Officer Other 667,524

13 Jul 2026 Harlow John B. Jr. Chief Commercial Officer Other 424,536

13 Jul 2026 THOMPSON JOHN CRAIG Director Other 79,873

13 Jul 2026 Fischer Seth H. Z. Director Other 141,023

13 Jul 2026 Shepard Jay Director Other 164,472

13 Jul 2026 Hoffman Robert E. Director Other 85,153

ESPR earnings

SEC EDGAR

Date Period EPS Revenue

31 Mar 2026 Q1 2026 $-0.10 $80M

31 Dec 2025 FY 2025 $-0.11 $403M

30 Sep 2025 Q3 2025 $-0.16 $87M

30 Jun 2025 Q2 2025 $-0.06 $82M

31 Mar 2025 Q1 2025 $-0.21 $65M

31 Dec 2024 FY 2024 $-0.28 $332M

30 Sep 2024 Q3 2024 $-0.15 $52M

30 Jun 2024 Q2 2024 $-0.33 $74M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

ESPR insider trades

ESPR earnings

ESPR institutional holders